Production of a recombinant S ( spike ) protein vaccine against SARS-CoV-2 and emerging coronaviruses
Production of a recombinant S ( spike ) protein vaccine against SARS-CoV-2 and emerging coronaviruses
针对 SARS-CoV-2 和新出现的冠状病毒的重组 S (spike) 蛋白疫苗的生产
批准号：
422769
负责人：
Houghton Michael
金额：
$43.71万
依托单位：
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2020
资助国家：
加拿大
项目状态：
已结题
起止时间：
2020-02-01 至 2022-02-01
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In December 2019 a human coronavirus (CoV) outbreak causing pneumonia-like symptoms began, centered around a fish market in the Wuhan district of China. After the genomic sequence was determined the causative pathogen, SARS-CoV-2, showed 99.98% identity a
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
COVID-19 Variant Supplement - Production of a recombinant S ( spike ) protein vaccine against SARS-CoV-2 and emerging coronaviruses
-
批准号：443190
-
项目类别：Operating Grants
-
资助金额：$3.64万
-
财政年份：2021
-
负责人：Houghton Michael
-
依托单位：
COVID-19 Variant Network - Production of a recombinant S ( spike ) protein vaccine against SARS-CoV-2 and emerging coronaviruses
-
批准号：443332
-
项目类别：Operating Grants
-
资助金额：$7.29万
-
财政年份：2021
-
负责人：Houghton Michael
-
依托单位：
Designing a component in prophylactic vaccine to induce broad cross-genotype neutralization against heterogeneous clades of HCV
-
批准号：409664
-
项目类别：Operating Grants
-
资助金额：$55.45万
-
财政年份：2019
-
负责人：Houghton Michael
-
依托单位：
Develop low-cost prophylactic vaccines against HCV, and therapeutic vaccines against HBV
-
批准号：229025
-
项目类别：
-
资助金额：$728.5万
-
财政年份：2010
-
负责人：Houghton Michael
-
依托单位：
海外基金
